The principal demand drivers are growth in chronic respiratory and related illnesses in addition to a rise in demand for and acceptance of home healthcare goods. The healthcare industry is growing to see extensive usage of nebulizers as a crucial treatment option for asthma and COPD. In light of these considerations, it is anticipated that the market for smart nebulizers will see substantial growth in the years to come. Nebulizers that are enabled by modern technology have the potential to become the next important contributor to the expansion of the smart nebulizers market.
The widespread use of oral medications and other treatment options, in addition to the availability of alternatives like metered-dose inhalers (MDI), has created substantial challenges to the expansion of the market for smart nebulizers. In order to successfully compete with their other rivals in the worldwide market for smart nebulizers, key firms in this industry have decided to create a new product. Participants in the sector anticipated making investments in the portfolio as a result of the growing prevalence of the inclusion of cloud computing into nebulizers. During the time period in question, one might anticipate an increase in demand for home care nebulizers. Companies that manufacture smart nebulizers are working hastily with a concentration on the needs of their customers.
Each year, the medical technology industry in the U.K. has a turnover of roughly $30 billion. It is supported by a solid foundation of mostly small to medium-sized enterprises located all across the nation, with concentrations of activity in regions like the South East of England and the Midlands. These tools have the potential to improve clinical outcomes and the patient experience throughout the entirety of the healthcare system. The medical technology market in Germany is the largest in Europe and the third-largest in the world. Germany is also the third-largest market overall.
The market participants have considerable investment potential in the Europe area as a consequence of the established medical device sector in the region, as well as the rising demand for innovative medical devices.
Based on Type, the market is segmented into Jet, Mesh and Ultrasonic. Based on End-use, the market is segmented into Hospitals & Clinics, Emergency Centers and Home Healthcare. Based on Application, the market is segmented into COPD, Asthma, Cystic Fibrosis and Others. Based on countries, the market is segmented into Germany, UK, France, Russia, Spain, Italy, and Rest of Europe.
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Omron Corporation, Koninklijke Philips N.V., Drive DeVilbiss Healthcare (Medical Depot, Inc.), Beurer GmBH, Vectura Group Plc (Philip Morris International, Inc.), Allied Healthcare Products, Inc., GE HealthCare Technologies, Inc., PARI GmbH, Aerogen Ltd.
Scope of the Study
Market Segments Covered in the Report:
By Type
- Jet
- Mesh
- Ultrasonic
By End-use
- Hospitals & Clinics
- Emergency Centers
- Home Healthcare
By Application
- COPD
- Asthma
- Cystic Fibrosis
- Others
By Country
- Germany
- UK
- France
- Russia
- Spain
- Italy
- Rest of Europe
Key Market Players
List of Companies Profiled in the Report:
- Omron Corporation
- Koninklijke Philips N.V
- Drive DeVilbiss Healthcare (Medical Depot, Inc.)
- Beurer GmBH
- Vectura Group Plc (Philip Morris International, Inc.)
- Allied Healthcare Products, Inc
- GE HealthCare Technologies, Inc
- PARI GmbH
- Aerogen Ltd
Unique Offerings
- Exhaustive coverage
- The highest number of market tables and figures
- Subscription-based model available
- Guaranteed best price
- Assured post sales research support with 10% customization free
Table of Contents
Chapter 1. Market Scope & Methodology1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 Europe Nebulizer Market, by Type
1.4.2 Europe Nebulizer Market, by End-use
1.4.3 Europe Nebulizer Market, by Application
1.4.4 Europe Nebulizer Market, by Country
1.5 Methodology for the research
Chapter 2. Market Overview
2.1 Introduction
2.1.1 Overview
2.1.1.1 Market Composition & Scenario
2.2 Key Factors Impacting the Market
2.2.1 Market Drivers
2.2.2 Market Restraints
Chapter 3. Europe Nebulizer Market by Type
3.1 Europe Jet Market by Country
3.2 Europe Mesh Market by Country
3.3 Europe Ultrasonic Market by Country
Chapter 4. Europe Nebulizer Market by End-use
4.1 Europe Hospitals & Clinics Market by Country
4.2 Europe Emergency Centers Market by Country
4.3 Europe Home Healthcare Market by Country
Chapter 5. Europe Nebulizer Market by Application
5.1 Europe COPD Market by Country
5.2 Europe Asthma Market by Country
5.3 Europe Cystic Fibrosis Market by Country
5.4 Europe Others Market by Country
Chapter 6. Europe Nebulizer Market by Country
6.1 Germany Nebulizer Market
6.1.1 Germany Nebulizer Market by Type
6.1.2 Germany Nebulizer Market by End-use
6.1.3 Germany Nebulizer Market by Application
6.2 UK Nebulizer Market
6.2.1 UK Nebulizer Market by Type
6.2.2 UK Nebulizer Market by End-use
6.2.3 UK Nebulizer Market by Application
6.3 France Nebulizer Market
6.3.1 France Nebulizer Market by Type
6.3.2 France Nebulizer Market by End-use
6.3.3 France Nebulizer Market by Application
6.4 Russia Nebulizer Market
6.4.1 Russia Nebulizer Market by Type
6.4.2 Russia Nebulizer Market by End-use
6.4.3 Russia Nebulizer Market by Application
6.5 Spain Nebulizer Market
6.5.1 Spain Nebulizer Market by Type
6.5.2 Spain Nebulizer Market by End-use
6.5.3 Spain Nebulizer Market by Application
6.6 Italy Nebulizer Market
6.6.1 Italy Nebulizer Market by Type
6.6.2 Italy Nebulizer Market by End-use
6.6.3 Italy Nebulizer Market by Application
6.7 Rest of Europe Nebulizer Market
6.7.1 Rest of Europe Nebulizer Market by Type
6.7.2 Rest of Europe Nebulizer Market by End-use
6.7.3 Rest of Europe Nebulizer Market by Application
Chapter 7. Company Profiles
7.1 Omron Corporation
7.1.1 Company Overview
7.1.2 Financial Analysis
7.1.3 Segmental and Regional Analysis
7.1.4 Research & Development Expenses
7.1.5 Recent strategies and developments:
7.1.5.1 Partnerships, Collaborations, and Agreements:
7.1.5.2 Acquisition and Mergers:
7.2 Koninklijke Philips N.V.
7.2.1 Company Overview
7.2.2 Financial Analysis
7.2.3 Segmental and Regional Analysis
7.2.4 Research & Development Expense
7.3 Vectura Group plc (Philip Morris International, Inc.)
7.3.1 Company Overview
7.3.2 Financial Analysis
7.3.3 Regional Analysis
7.3.4 Research & Development Expenses
7.3.4.1 Partnerships, Collaborations, and Agreements:
7.4 Allied Healthcare Products, Inc.
7.4.1 Company Overview
7.4.2 Financial Analysis
7.4.3 Regional Analysis
7.4.4 Research & Development Expenses
7.5 Drive DeVilbiss Healthcare (Medical Depot, Inc.)
7.5.1 Company Overview
7.6 Beurer GmbH
7.6.1 Company Overview
7.7 GE HealthCare Technologies, Inc.
7.7.1 Company Overview
7.8 PARI GmbH
7.8.1 Company Overview
7.9 Aerogen Ltd.
7.9.1 Company Overview
Companies Mentioned
- Omron Corporation
- Koninklijke Philips N.V.
- Drive DeVilbiss Healthcare (Medical Depot, Inc.)
- Beurer GmBH
- Vectura Group Plc (Philip Morris International, Inc.)
- Allied Healthcare Products, Inc.
- GE HealthCare Technologies, Inc.
- PARI GmbH
- Aerogen Ltd.
Methodology
LOADING...